Latest AI and machine learning research in skin cancer for healthcare professionals.
Tumor Mutational Burden (TMB) is a widely used biomarker for selecting cancer patients for immune ch...
Accurate in silico identification of B-cell epitope residues is crucial for antibody design and stru...
Tertiary lymphoid structures (TLS) have been observed in solid tumors and have been associated with ...
Immune checkpoint blockade has emerged as a promising form of cancer therapy. However, only some pat...
Decoding cellular systems requires integrating diverse omics data, yet most models are trained from ...
Biomarker discovery for immunotherapy often requires reasoning across complex immune contexts. We pr...
Class I major histocompatibility complexes (MHCs), expressed on the surface of all nucleated cells, ...
This work introduces a modular, open-source computational pipeline for glioblastoma (GBM) vaccine de...
Stain imputation in multiplex immunofluorescence (mIF) imaging addresses the challenge of missing or...
Synthetic enhancers with high specificity are crucial for therapeutic gene control. Although existin...
This work introduces a modular, open-source computational pipeline for glioblastoma (GBM) vaccine de...
Single-cell RNA sequencing technologies have revolutionized our understanding of cellular heterogene...
Melanoma outcomes have dramatically improved over the past decade, but some patients still experienc...
Multiplexed imaging technologies now enable the simultaneous profiling of hundreds to thousands of m...
Digital pathology has significantly advanced cancer diagnosis by enabling high-resolution visualisat...
Decisions on the best available treatment in clinical oncology are based on expert opinions in multi...
To evaluate the potential of wrist-worn wearable devices to detect and quantify Faciobrachial Dyston...
To synthesize existing literature on patient attitudes toward AI in cancer care and identify knowled...
Neoantigens have emerged as promising targets for personalized cancer immunotherapy. However, accura...
Patients with rare cancers face substantial challenges due to limited evidence-based treatment optio...
Merkel cell carcinoma (MCC) is a rare cutaneous neuroendocrine malignancy with a higher case-fatalit...